In disease prognostic models, ANGPTL4 has demonstrated diagnostic potential, with an AUC of 0.7665, and its expression in RCC tumor samples is significantly greater than that in normal kidney tissue (Li L. et al., 2023). The gene discussed is ANGPTL4; the disease is renal cell carcinoma.